FIELD: pharmaceutics, medicine.
SUBSTANCE: the present innovation deals with cardiotherapy for treating and preventing coronary deficiency. The preparation is designed as a plate (film) consisted of three layers, each of them is manufactured out of co-polymer of vinyl pyrrolidone, acrylamide and nitroglycerin-containing ethylacrylate; moreover, internal layer additionally contains solid fat - cacao oil, and weight ratio for the sum of external layers to internal corresponds to 1 : 1. The suggested preparation could additionally contain brilliant green dyestuff. The preparation should be manufactured out of pre-obtained mixture of nitroglycerin and copolymer in solution of alcohol and water followed by layer-by-layer forming three-layer film due to spreading the mixture onto solid bottom plate and drying at 30-50 C. The innovation provides higher adhesion to gingival mucosal surface, decreased side action, improved bioavailability and stability of therapeutic effect.
EFFECT: higher efficiency of therapy.
3 cl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
ANTIANGINAL AGENT | 0 |
|
SU806037A1 |
AGENT FOR FLUORESCENT DIAGNOSIS AND PHOTODYNAMIC THERAPY ON ONCOLOGICAL AND NON-ONCOLOGICAL DISEASES | 2002 |
|
RU2219921C1 |
AGENT FOR PLATELET AGGREGATION DECREASE IN CIRCULATORY SYSTEM | 1995 |
|
RU2095064C1 |
CHOLESTYRAMINE PELLETS, ORAL CHOLESTYRAMINE COMPOSITIONS AND THEIR USE | 2018 |
|
RU2782016C2 |
ORAL CHOLESTYRAMINE COMPOSITION AND APPLICATION THEREOF | 2017 |
|
RU2750937C2 |
MEDICINAL PREPARATION FOR NORMALIZING SEXUAL POTENCY IN MALES | 1994 |
|
RU2036644C1 |
CHOLESTYRAMINE PELLETS AND THEIR PRODUCTION METHODS | 2017 |
|
RU2775800C2 |
ORAL CHOLESTYRAMINE COMPOSITION AND APPLICATION THEREOF | 2017 |
|
RU2750944C2 |
METHOD OF DIABETES TREATMENT | 2007 |
|
RU2442585C2 |
PHARMACEUTICAL DRUG FORM OF TYROSINE KINASE INHIBITOR FOR PERORAL INTRODUCTION | 2007 |
|
RU2468788C2 |
Authors
Dates
2005-05-27—Published
2004-02-17—Filed